Hallucinations linked to drug given to troops
Malaria medication can cause paranoia, other mental side effects
As a volunteer firefighter, Georg-Andreas Pogany had seen disfigured bodies pulled from wrecked cars. But something very different happened when the Army interrogator saw the mangled remains of an Iraqi soldier.
He became panicked, disoriented and that night reached for both his loaded pistol and rifle as he thought he saw the enemy bursting into his room. Pogany asked his superiors for help; the Army packed him home to face charges of cowardice — the first such case since Vietnam.
None of it made sense to Pogany until he learned more about the white pills the Army gave him each week to prevent malaria.
Pills made him
snap, says soldier
The drug’s manufacturer warned of rare but severe side effects including
paranoia and hallucinations. It became his defense: The pills made him
snap. The Army dropped all charges, a spokesman later saying that Pogany
“may have a medical problem that requires care and treatment.”
Pogany is among the current or former troops sent to Iraq who claim that Lariam, the commercial name for the anti-malarial drug mefloquine, provoked disturbing and dangerous behavior. The families of some troops blame the drug for the suicides of their loved ones. Though the evidence is largely anecdotal, their stories have raised alarm in Congress, and the Pentagon has stopped giving out a pill it probably never needed to give to tens of thousands of troops in Iraq in the first place.
“What are we doing giving drugs that cause hallucinations, confusion, psychotic behavior to people that carry weapons and hold secret clearances?” asked Pogany, 33, who is now seeking a medical discharge. “It doesn’t pass the common-sense test.”
Military issues
guidelines
The U.S. military, which developed the drug after the Vietnam War,
maintains that Lariam is safe and effective, though officials have
expressed some concern and the military tells its pilots not to take
Lariam.
In written guidance on the drug last year, the military urged commanders to send for a medical evaluation anyone who showed behavioral changes after taking the drug, “especially ... if they carry a weapon” — a description of nearly all U.S. troops in Iraq.
“Delay could put the service member or your unit at risk,” the guide said.
Lariam is among the drugs recommended by the U.S. Centers for Disease Control and Prevention for treatment and prevention of malaria, which kills about 1 million people worldwide each year. The drug’s New Jersey-based manufacturer, Roche Pharmaceuticals, points out that more than 30 million people worldwide have used Lariam over 20 years.
“There is no reliable scientific evidence that Lariam is associated with violent acts or criminal conduct,” Roche spokesman Terence Hurley wrote in an e-mailed response to questions.